Haisco Pharmaceutical Group: Announcement regarding the sale of overseas subsidiary and the achievement of the second milestone payment for TYK2 product in R&D
Hisco: Announcement on the sale of TYK2 products from overseas holding subsidiaries and ongoing research projects to obtain the first milestone
Hisco: 2021 Annual Equity Distribution Implementation Notice
Hisco: Announcement on 2021 Profit Distribution Plan
Hisco: Announcement on the subscription of shares of Chengdu Haichuang Pharmaceutical Co., Ltd.
Hisco: Announcement on the termination of the public offering of convertible corporate bonds
Hisco: Announcement on 2018 interest payment/payment of the first instalment of the 2017 short-term financing notes
Hisco: Announcement on the issuance of the first issue of short-term financing notes in 2017
Hisco: Announcement on the approval of registration of the company's short-term financing notes and medium-term notes
Hisco: Announcement on Transfer of Shares and Related Transactions of Participating Companies
Hisco: Announcement on proposed issuance of medium-term notes
Hisco: Announcement on Proposed Issuance of Short-Term Financing Notes
Hisco: Announcement of Resolutions of the 13th Meeting of the Second Board of Directors
Hisco: Announcement on Using Idle Raised Funds to Purchase Capital Protected Bank Wealth Management Products
Hisco: China Securities Regulatory Commission's approval for the company's initial public offering of shares